Lp(a), a new lipid frontier in CV risk management & target for therapy
Meeting report with presentation slides, videos and online CME of a PACE-CME symposium held during ESC 2020, The Digital Experience.
Episodes 1-4 of 4
- Lp(a), a new lipid frontier in CV risk management & target for therapyIntroduction: Lp(a), a new lipid frontier in CV risk management & target for therapy
Prof. Erik Stroes, MD
- Lp(a), a new lipid frontier in CV risk management & target for therapyIs there a role for PCSK9 inhibition in patients with high Lp(a)?
Prof. Vera Bittner, MD
- Lp(a), a new lipid frontier in CV risk management & target for therapyNovel strategies to lower Lp(a)
Prof. Sam Tsimikas
- Lp(a), a new lipid frontier in CV risk management & target for therapyWhy worry about high Lp(a) and how to assess Lp(a) levels?
Pia Kamstrup, MD, PhD
